Background/objectives: The use of the sole third finger middle phalanx for a maturational method has been proposed but not fully investigated. Herein, the diagnostic reliability of an improved fivestage third finger middle phalanx maturation (MPM) method in the identification of mandibular growth peak has been investigated. Subjects/methods: From the files of the Burlington Growth Study, 35 subjects (20 males, 15 females) with at least 7 annual lateral cephalograms taken from 9 to 16 years were included. Mandibular growth was defined as annual increments in condylion-gnathion (Co-Gn) distance. Subsequently, individual annual increments in Co-Gn were arranged according to annual age intervals, with the first and last intervals defined as 9-10 years and 14/15-16 years, respectively. A full diagnostic reliability analysis (including positive likelihood ratio) was performed to establish the diagnostic reliability of the MPM stage 2 (MPS2) in the identification of the imminent mandibular growth peak. Results: The MPS2 had a satisfactory accuracy in the identification of imminent mandibular growth peak with an overall positive likelihood ratio of 10.3. However, reliability showed noteworthy variability being greater and lower for younger and older age intervals, respectively. Limitations: Secular trend, limited sample size, and annual recording in conjunction with the use of a discrete staging system. At the 15 years recording, 28 of 35 cases were missing. Conclusions/implications: The MPS2 and MPS3 may be considered associated with the onset and maximum mandibular growth peak, respectively, in most of the subjects, indicating their use in planning treatment timing.
Introduction
Recent evidence has shown how the use of skeletal maturation indicators is associated to a better response in terms of mandibular elongation in Class II patients treated by removable (1) or fixed (2) functional appliances. Among the most common investigated growth indicators are the hand-and-wrist maturation (HWM) method in different variants (3) (4) (5) (6) , and the cervical vertebral maturation (CVM) method (7, 8) . These indicators may enhance the efficiency of the functional treatment by the identification of the timing of mandibular growth peak, where individual response is supposed to be optimal (9) . However, investigations on the reliability of the skeletal maturation indicators in the identification of the mandibular growth peak are based on correlation analyses (10-13), which do not necessarily imply diagnostic reliability (14, 15) . In spite of the large number of studies on maturational indicators, only one investigation (16) has reported on the diagnostic capability of the CVM method in the identification of the mandibular growth peak in individual subjects.
The use of the sole third finger middle phalanx (MP3) for a maturational method has been proposed (17) (18) (19) . This method would European Journal of Orthodontics, 2017, 194-201 doi:10.1093/ejo/cjw059 Advance Access publication 27 September 2016 have advantage of easy interpretation and minimal radiation exposure allowing a limited repetition of recordings to monitor the maturational process. In particular, a recent version of the method referred to as the middle phalanx maturation (MPM) method, including six stages, has been correlated with the CVM method (18) . However, such study (18) was limited by the cross-sectional design and did not include any investigation on the mandibular growth. Therefore, the diagnostic capability of the MPM method in the identification of the mandibular growth peak remains an open issue.
The present study used files from the Burlington Growth Study to carry out a 7-year longitudinal circumpubertal analysis of individual MPM morphological changes in relation to the mandibular growth. Herein, the diagnostic reliability of an improved five-stage version of the MPM method in assessing the mandibular growth peak has initially been reported. This study ultimately verified whether the improved MPM method, as proposed herein, may be a candidate as a tool to determine treatment timing in individual patients.
Materials and Methods

Study design
Participants were selected from the records of the Burlington Growth Study, extracted from the American Association of Orthodontists Foundation (AAOF) Craniofacial Growth Legacy Collection (www. aaoflegacycollection.org). Subjects were selected for inclusion if they had unbroken series of recordings from 9 to 16 years, including both lateral cephalograms and corresponding hand-and-wrist films. In consideration that most of the Burlington Growth Study cases miss the 15 years recording, this specific recording was used whenever present (see also below), accounting for a total of at least 7 recordings per subject. An attempt was made in the inclusion of subjects with normal growth having overall ANB angle between 0° and 6° and total facial divergence (as the angle between the sella-nasion line and mandibular plane) between 25° and 42°. Exclusion criteria were: 1. incomplete records; 2. radiographs of poor diagnostic quality; 3. subjects with recognizable craniofacial (or other) conditions or syndromes; and 4. in case of evident orthodontic treatment (with exception for minimal treatment, such as space maintainers). From an original sample of 100 cases available on the AAOF Craniofacial Legacy Collection, after selection, 35 subjects (20 males, 15 females, born between 1949 and 1951) were included in the study accounting for a total of 502 recordings (equally distributed between lateral cephalograms and hand-andwrist films). According to the information provided by the Burlington Growth Centre, a 9.84 per cent magnification factor has been used in these recordings. Therefore, by a slight approximation, a magnification factor of 10 per cent has been adopted.
Total mandibular length assessment and identification of the mandibular growth peak A customized digitization regimen and analysis with a cephalometric software (Viewbox, version 3.0, dHAL Software, Kifissia, Greece) was used for all cephalograms examined in this study. Total mandibular length was measured using the distance between condylion (Co) and gnathion (Gn) for each recording. All cephalograms were traced by an operator (VS) and checked for accuracy by a second investigator (LC).
Increments of Co-Gn distance were calculated for each subject according to each annual age intervals from 9-10 years to the last biannual 14-16 years (or again to the annual 14-15 years and 15-16 years intervals, where possible). Since annual intervals not always lasted for exactly 12 months, annualized increments were derived (even from the biannual 14-16 years interval). The individual MPM stage at the beginning of each annual (or 14-16 years biannual) age interval also was recorded. Finally, the annual (or 14-16 years biannual) age interval of maximum individual increment for Co-Gn distance was identified as the one displaying the greatest increment of the whole series, i.e. mandibular growth peak, and subsequently was used for diagnostic reliability analysis. For descriptive purposes, annualized mean ± standard deviation of CoGn distance increments were calculated according to each annual (or biannual) age interval for females and males.
Third finger middle phalanx maturation assignment
The improved MPM method as proposed herein comprises five stages [middle phalanx stages, (MPS)], instead of six stages initially proposed (18) . A diagram of the MPM stages are shown in Figure 1 , while definitions of the stages were based on previous descriptions by Fishman (5), Hägg and Taranger (3) and Rajagopal and Kansal (19) , with modifications summarized in Table 1 . More in detail, the MPS5 as earlier reported (18) has herein been merged with stage 4. An experienced orthodontist (GP), who was blinded to the cephalometric data assessed the improved MPM stages.
Method error and data analysis
The method of moments variance estimator was used (20) to evaluate the method error of the recordings for each cephalometric parameter. This analysis was performed on 20 pairs of recordings randomly selected and expressed as mean [95% confidence interval (CI)]. The repeatability in the MPM stage assignment in further 20 pairs of cases randomly selected was evaluated using the percentage of agreement and by both unweighted and linear weighted κ coefficients presented as mean (95% CI) (21) . 
Statistical analysis and diagnostic reliability assessment
For both the male and female subjects, average growth curves were plotted for annualized increments of total mandibular length (as Co-Gn distance). When constructing the curves, individual mandibular growth peaks were aligned (registered), and the annualized increments for the peak and each prior and succeeding interval were averaged not more than 3 years before and after. After having tested existence of required assumptions (22) , a Mann-Whitney U-test assessed the significance of the difference between the genders at each annual interval. For each MPM stages 2 and 3, the corresponding chronological ages were used to derive the individual durations of each stage. Subsequently, the mean and standard deviation of the duration of these stages were calculated. Due to the missing recording at 15 years for most of the examined samples, duration of the stages 2 and 3 were reliably derived from a subset of subjects, while duration of the stage 4 could not be calculated on a representative number of subjects.
Diagnostic reliability assessment was calculated for each annual age interval and included sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), accuracy (23) , and positive likelihood ratio (LHR) (24) . Moreover, for each diagnostic parameter, overall weighted mean was also calculated taking into account the paired nature of the data. Each diagnostic parameter has been presented as mean and (95% CI). This analysis evaluated the capability of the circumpubertal MPS2, MPS3, and MPS4 in the identification of the maximum individual increments of Co-Gn distance according to a previously reported procedure (16) . However, only data regarding the MPS2 are shown being mostly related to the mandibular growth peak.
More in detail, the positive LHR incorporates both the sensitivity and the specificity of the test, and it provides a direct estimate of how much a test result changes the odds of having a condition (23) . A threshold of a positive LHR equal or greater than 10 (24) is generally considered for assessment of satisfactory reliability.
The Microsoft Excel 2016 (Microsoft, Redmond, Wash), SPSS software 13.0 (SPSS® Inc., Chicago, Illinois, USA), MedCalc® software 12.3.3.0 (MedCalc Software, Mariakerke, Belgium), Comprehensive Meta-Analysis software 2.0 (Biostat Inc., Englewood, NJ, USA), and the interactive Stats Calculator (http:// ktclearinghouse.ca/cebm/practise/ca/calculators/statscalc) were used to perform the statistical analyses. A P value less than 0.05 was considered as significant.
Results
Method errors for the Co-Gn distance was 0.86 mm (0.59-1.13). The full list of the individual MPM stages from 9 to 14 years (beginning of the last biannual recording) and corresponding following annual increments in Co-Gn distance according to each annual age interval is summarized in Table 2 . A total of 7 subjects of 35 also had recordings at 15 years. All of the cases, with one exception (595), had an MPS1 at the beginning of the monitoring. Males showed generally later maturation stages as compared to females. The MPS2 was seen in all the subjects with one exception (153), the MPS3 was seen in 26 subjects (considering 5 cases according to the available recordings at 15 and 16 years, not shown in Table 2 ), missed in 2 subjects (871, 198) and not derivable in the rest of the subjects. The MPS4 was seen in 14 subjects (including 6 cases according to the available recordings at 15 and 16 years, not shown in Table 2 ), missed in 1 subject (316) and not derivable in the rest of the subjects. The duration of each MPM stage 2 to 4 was generally 1 year, with few exceptions. The MPS2 lasted for to 2 years in 9 subjects (135, 366, 706, 742, 871, 198, 321, 487, 631), the MPS3 lasted for 2 years in 3 subjects [391, 595 and 636 (including 15 and 16 years)], and MPS4 lasted for 2 years in 5 subjects (153, 198, 595, 602, 855) . The mean duration in years of each MPS2 and MPS3 for the whole group could be derived only on subsets of 25 and 21 subjects (taking into account missing recordings at 15 years) and were 1.3 ± 0.5 years and 1.1 ± 0.4 years, respectively. No meaningful Reported as MP3-F and described to be attained more than 1 year before the onset of the pubertal growth spurt (3).
MPS 2 When the epiphysis is at least as wide as the metaphysis with sides increasing thickness and showing a clear line of demarcation at right angle, either with or without lateral steps on the upper contour. In case of asymmetry between the two sides, the more mature side is used to assign the stage.
Reported as SMI2 (5), or as MP3-FG described to be attained 1 year before the pubertal growth spurt (3).
MPS 3 When the epiphysis is either as wide as or wider than the metaphysis with lateral sides showing an initial capping towards the metaphysis. In case of asymmetry between the two sides, the more mature side is used to assign the stage. Epiphysis and metaphysis are not fused.
Reported as SMI6 (5) or as MP3-G, both described to be attained at coincidence of the pubertal growth spurt (3).
MPS 4 When the epiphysis begins to fuse with the metaphysis although contour of the former is still clearly recognizable. Both sides of the epiphysis form obtuse angle to distal border, and the capping may still be detectable.
Reported as MP3-H and described to be attained after the pubertal growth spurt, i.e. during the deceleration of the curve of growth (3).
MPS 5 When the epiphysis are totally fused with the metaphysis. Reported as SMI10 (5) or as MP3-I, both described to be attained at the end of the pubertal growth spurt (3).
comparison could be made between the sexes because of the limited sizes of these subsets. The values of annualized increments in Co-Gn distance ranged from 2.5 mm (742, 13-14 years) to 7.5 mm (166, 13-14 years). Males showed generally later mandibular growth peaks as compared to females. Most of the mandibular growth peaks were seen in the 11-12 years (n = 8) and 13-14 years (n = 7) and 14-16 years (n = 11).
The annualized increments of mandibular growth, in register according to the peaks, is shown in Figure 2 . The maximum annualized mandibular growth values (as mean ± standard deviation) were 4.7 ± 1.5 mm and 4.2 ± 0.8 mm in males and females, respectively, with no significant difference (P = 0.482). All the other mean values were generally below 2 mm with no significant differences between the gender. A slight tendency towards a 'minimum pre-pubertal' growth has been seen the year preceding the maximum mandibular growth both in males and in females.
A clinical example of a subject (544, male) with full tracings of the third finger middle phalanx at each actual age (including the 15 years) is shown in Figure 3 . In this case, each MPM stage from 2 to 5 lasted for about 1 year. Moreover, for the same subject, a superimposition of the tracings of the mandible at each annual recording along with actual ages, MPM stages and Co-Gn distances, is shown in Figure 4 . In particular, the mandibular growth peak occurred at the 12-13 years with an MPS2 at 12.2 years and an MPS3 at 13.3 years. Results on the diagnostic reliability assessment of the MPS2 in the identification of the mandibular growth peak and according to each annual age interval are summarized in Table 3 . Mandibular growth peaks occurred in all the annual age intervals. By excluding the 9-10 yrs interval, where only 2 peaks were seen and the positive LHR could not be calculated, sensitivity ranged from 0.82 (14-16 years) to 1 (10-11 years and 12-13 years); specificity ranged from 0.86 (13) (14) The raw Co-Gn distances and other information are also summarized in Supplementary Table 1 .
Discussion
This study was designed to address whether the MPM method has satisfactorily diagnostic accuracy in the identification of the mandibular growth peak and, in such a case, which stage may most reliably be associated with imminent growth peak. In particular, the MPM stages and increments in total mandibular length were recorded longitudinally and analysed in a group of untreated subjects according to the different predetermined annual (chronological) age intervals (16) . The results show that the MPS2 generally precedes the mandibular growth spurt, which is, in several cases, concomitant to MPS3. However, even though the overall diagnostic accuracy is satisfactory, in the older age ranges, the method appears less reliable.
To assess the posterior end point of the mandible, the present study used the landmark condylion instead of articulare, as has been done in several previous investigations (5, (25) (26) (27) (28) (29) , since articulare is not an anatomical landmark that pertains to the mandible exclusively. The annual rate of the total mandibular length seen herein (Figure 2 ) is similar to previous evidence reported for Class I untreated subjects (30) . The mandibular growth peak occurred very early or late in several subjects (Table 2) , making the use of a determined age range unreliable. The present evidence is thus consistent with previous reports showing that age remains a poorly reliable parameter in determining the onset of the pubertal growth spurt (3) or mandibular growth peak (5, 8, 31) .
The difficulty of obtaining diagnostic parameters from longitudinal data in a subset of selected subjects all with a predetermined condition (mandibular growth peak) or a diagnostic outcome (a given MPM stage) has been reported as one of the reasons why in previous studies (3,5,6,8,10-13,31,32) diagnostic accuracy of the different growth indicators with mandibular/body growth peak has conjecturally been based on correlation analyses (16) . Thus, the present results cannot be compared with previous reports for the MP3 maturation method (17, 19) or the whole HWM method (5, 6, 31, 32) .
Sensitivity and specificity for the MPS2 in the identification of imminent mandibular growth peak were generally high ranging with overall values of 0.84 and 0.92, respectively. However, while specificity reached a satisfactory level in all the age ranges (from 0.88 to 1), sensitivity dropped to 0.5 at 9-10 years interval (Table 3) . Apart, this 9-10 years interval, which had only 2 cases of mandibular peak, generally, the lower sensitivity was seen for the older age intervals. Therefore, while overall sensitivity was acceptable, its 95% CI (0.57-1) would partially limit the reliability of the MPM method. In this regard, studies with larger sample sizes are warranted.
When dealing with several possible clustering, an important diagnostic parameter is the PPV that gives an indication of the capability of a given MPM stage in the identification of the mandibular growth peak, irrespective of the number of true negative cases belonging to the other stages. Herein, the overall PPV and NVP values for the MPS2 in the identification of the mandibular growth peak were 0.73 and 0.93, respectively (Table 3) . Indeed, for the 35 subjects, in 30, 3 and 2 cases, mandibular growth peak was preceded by a MPS2, MPS1, and MPS3, respectively. However, due to the biannual duration of the MPS2 (seen in 9 subjects), there also were 11 cases where the MPS2 was not immediately followed by a mandibular growth peak (Table 2) . Therefore, misdiagnosis would mainly due to false positives, while negative cases (not MPS2) would be highly reliable.
Calculation of the accuracy and the positive LHRs takes into account both the identification of true positive and true negative cases. The accuracy of the MPS2 in the identification of imminent mandibular growth peak ranged between 0.86 and 0.97, while the positive LHRs were in the range of 6.0 to 16.0. For both parameters, greater the chronological age interval, lower the diagnostic parameter (Table 3 ). In particular, while the overall positive LHR was satisfactory (10.3), in the 13-14 years and 14-16 years intervals, it did not reach the threshold of 10. Interestingly, the CVM stages 3-4 taken together have been shown to have a generally lower accuracy, as compared to that of the MPS2, which ranged between 0.67 and 1, again with lower scores in the older age intervals (16) .
Previous investigations (31, 32) on the correlation between the maturation of the third finger middle phalanx and peak height velocity reported a close concurrence of the attainment of MP3 stage G (equivalent to the maturation from MPS2 to MPS3) with the peak height velocity in both males and females. Another investigation (6) on a sample of aboriginal children from Australia reported that peak height velocity would occur up to 3 and 6 months later, in males and females, respectively, of the attainment of the MP3 stage G. Taking into account that these previous longitudinal investigations used peak height velocity instead of mandibular growth peak, the present results would be consistent with reported evidence (Figures 3 and 4) .
Of interest, a previous cross-sectional study (18) showed 73 per cent agreement between the MPM and CVM methods (variants with 6 stages each), especially up to the stages 4, while another longitudinal study (13) reported that mandibular growth peak would occur earlier than the CVM stages 3 and 4. Therefore, the present results indicating a mandibular peak between the MPM stages 2 and 3 would be consistent with these previous reports.
Proper planning of treatment timing, especially when dealing with functional treatment for skeletal Class II malocclusion, requires the knowledge of the duration of the different stages in individual subjects. Ideally, MPM stages 2 and 3 should have precise durations in a way that interventions may be easily planned on a basis of a single film. Due to fine morphological transitions and under an annual recording regimen, a given stage may be apparently missing, while the preceding or the subsequent may last for 2 years. This would be a limitation of any discrete maturity index. Herein, the MPS2 lasted for 1.3 years, however, as it has been seen for the HWM (31) and CVM (33) methods, the intra-subjects duration of each single stage may be variable. In this regard, both the HWM and the CVM methods require films that are usually available as a pre-treatment record, while optimal treatment timing is to be delayed for an undermined term after the diagnosis. Therefore, further re-evaluation of the growth phase needs a re-execution of either a hand-and-wrist or a lateral head film, which would not be indicated for this purpose according to the most recent guidelines (28) . On the contrary, the MPM method, being based on very limited area and using minimal radiation, as low as 7 mA for less than 0.01 s (18) , may be repeated to closely follow the ossification events. Moreover, radiograph of the third finger middle phalanx may be easily taken using any dental X-ray machine with a standard 3 × 4 cm periapical sensor (Supplementary Figure 1) . Thus, the method would overcome limitations imposed by the use of single stages that have variable duration (25) . However, the lower diagnostic reliability seen in the older age intervals, along with previous evidence (12, 31) , suggests that a single indicator (especially under a single recording regimen) would not be sufficient to properly identify the mandibular growth peak in all the subjects. A combinational use of the MPM method with another non-invasive indicator, such as standing height, might be helpful to increase diagnostic reliability. Nevertheless, the present results warrant further longitudinal studies on different and larger Table 3 . Diagnostic reliability of the third finger middle phalanx stage 2 in the identification of the mandibular growth peak as annualized incretment in Co-Gn distance according to each annual age interval from 9 to 16 years. Data are presented as mean (95% confidence interval) with n = 35 in each age interval. LHR = likelihood ratio; PPV = positive predictive value; NPV = negative predictive value; -= not derivable. samples and clinical trials on the efficiency of functional treatment for skeletal Class II malocclusion when timing is based according to the MPM method.
Strengths and limitations
In the present study, a full transparent reporting has been followed after cephalometric recording by the use of known longitudinal lateral head films, along with the reporting of the detailed case-bycase outcomes. A full diagnostic performance analysis of the MPM method (stage 2) in the identification of the imminent mandibular growth peak has initially been reported. Among the limitations are the secular trend (34), the limited sample size, and the annual recording, which has inherent error in conjunction with the use of a discrete staging system. Eight of the mandibular growth peaks were seen in concomitance with the lack of the 15 years recording.
Clinical implications
The MPS2 and MPS3 may be considered associated with the onset and maximum mandibular growth peak, respectively, in most of the subjects and may therefore be used for planning treatment timing for functional treatments especially for skeletal Class II malocclusion (8, 9) where optimal timing would be during the interval between the MPM stages 2 and 3. Moreover, the minimal radiation exposure would allow for a close monitoring of the ossification events by longitudinal recordings, with a more precise definition of the timing of treatment in individual patients. Finally, the MPM method is of easy execution and interpretation and may be performed in any clinical setting with minimal instrumentation.
Conclusions
• The MPS2 has an overall satisfactory accuracy in the identification of imminent mandibular growth peak, as recorded through the annual increments of Co-Gn distance.
• However, diagnostic reliability of the MPS2 is also subjected to noteworthy variability, suggesting a combinational use with another non-invasive indicator to increase diagnostic reliability.
Supplementary material
Supplementary material is available at European Journal of Orthodontics online.
